Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

Rx/Reimbursement adult incontinence in

Rx/Reimbursement Adult Incontinence in Belgium

Jun 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PRE-COVID-19 PERFORMANCE

Promotion of incontinence allowance widens awareness in 2019

Like retail adult incontinence, RX/reimbursement adult incontinence benefited from an ageing population in 2019, while this product area was also boosted by growth in the number of care homes across Belgium during the review period. As the population ages, the government has sought to improve care for this group.

Expansion in number of elderly care homes benefits 2019 sales

RX/reimbursement adult incontinence continued to benefit from growth in the number of healthcare institutions for elderly people in 2019. These institutions are fully aware of the social funds allocated for the reimbursement of these products and communicate this to their patients.

Ontex retains lead in 2019 via low prices, high quality and Belgian heritage

Domestic player Ontex Global remained the main player in RX/reimbursement adult incontinence in 2019, working closely with the government to supply these products. This player benefits from its strength in retail adult incontinence and AFH adult incontinence, while also being a private label supplier of these products.

2020 AND BEYOND

COVID-19 impact

Sales of RX/reimbursement adult incontinence are expected to grow by 2% in constant 2019 value terms in 2020 in light of the impact of COVID-19.

Affected products within RX/reimbursement adult incontinence

All product areas within RX/reimbursement adult incontinence have been impacted equally by shortages during the initial stages of the COVID-19 pandemic. However, these shortages are likely to be temporary, with the pandemic not expected to have a significant impact on forecast period growth as a whole.

Recovery and opportunities

RX/reimbursement adult incontinence is expected to see good growth in the forecast period as a whole. After the initial impact of COVID-19, demand will continue to benefit from population ageing and from the fact that the government is keen to woo elderly voters, thus continuing to promote its allowance for incontinence sufferers.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

SAMPLES

FAQS ABOUT SAMPLES

DELIVERY

Files are delivered directly into your account within a few minutes of purchase.

OVERVIEW

Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement adult incontinence industry in Belgium with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Rx/Reimbursement adult incontinence industry in Belgium, our research will save you time and money while empowering you to make informed, profitable decisions.

The Rx/Reimbursement adult incontinence in Belgium market research report includes:

Analysis of key supply-side and demand trends
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Rx/Reimbursement adult incontinence in Belgium?
What are the major brands in Belgium?
What are the most important channels for Rx/Reimbursement adult incontinence products?
How do light incontinence products perform compared to moderate/heavy incontinence products?

WHY BUY THIS REPORT?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our

Tissue and Hygiene market research database

Want to find out more about this report?

Request more information

Rx/Reimbursement Adult Incontinence in Belgium - Category analysis

HEADLINES

PRE-COVID-19 PERFORMANCE

Promotion of incontinence allowance widens awareness in 2019

Expansion in number of elderly care homes benefits 2019 sales

Ontex retains lead in 2019 via low prices, high quality and Belgian heritage

2020 AND BEYOND

COVID-19 impact

Affected products within RX/reimbursement adult incontinence

Recovery and opportunities

CATEGORY DATA

Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2014-2019
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2014-2019
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024

Tissue and Hygiene in Belgium - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on tissue and hygiene

COVID-19 country impact

Organic and natural products offer growth opportunities in 2019 despite overall maturity

Discounters and private label put heavy pressure on prices in 2019

Consumers to focus on preventative health post-COVID-19, but few opportunities for significant growth due to market maturity

Chart 1 Tissue and Hygiene Value Sales Growth Scenarios: 2017-2024
Chart 2 Tissue and Hygiene Impact of Soft Drivers on Value Sales: 2016-2024

MARKET INDICATORS

Table 5 Birth Rates 2014-2019
Table 6 Infant Population 2014-2019
Table 7 Female Population by Age 2014-2019
Table 8 Total Population by Age 2014-2019
Table 9 Households 2014-2019
Table 10 Forecast Infant Population 2019-2024
Table 11 Forecast Female Population by Age 2019-2024
Table 12 Forecast Total Population by Age 2019-2024
Table 13 Forecast Households 2019-2024

MARKET DATA

Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2014-2019
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2014-2019
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2015-2019
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2016-2019
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2014-2019
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2014-2019
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2019
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024

Megatrends

Country Report

Rx/Reimbursement Adult Incontinence in Belgium

New Report Guarantee

Executive Summary

New Report Guarantee

PRE-COVID-19 PERFORMANCE

Promotion of incontinence allowance widens awareness in 2019

Expansion in number of elderly care homes benefits 2019 sales

Ontex retains lead in 2019 via low prices, high quality and Belgian heritage

2020 AND BEYOND

COVID-19 impact

Affected products within RX/reimbursement adult incontinence

Recovery and opportunities

Overview

Why buy this report?

SAMPLES

DELIVERY

OVERVIEW

WHY BUY THIS REPORT?

Want to find out more about this report?

Table of Contents

Rx/Reimbursement Adult Incontinence in Belgium - Category analysis

HEADLINES

PRE-COVID-19 PERFORMANCE

Promotion of incontinence allowance widens awareness in 2019

Expansion in number of elderly care homes benefits 2019 sales

Ontex retains lead in 2019 via low prices, high quality and Belgian heritage

2020 AND BEYOND

COVID-19 impact

Affected products within RX/reimbursement adult incontinence

Recovery and opportunities

CATEGORY DATA

Tissue and Hygiene in Belgium - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on tissue and hygiene

COVID-19 country impact

Organic and natural products offer growth opportunities in 2019 despite overall maturity

Discounters and private label put heavy pressure on prices in 2019

Consumers to focus on preventative health post-COVID-19, but few opportunities for significant growth due to market maturity

MARKET INDICATORS

MARKET DATA

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Recently Viewed

Complete Catalogue

Country Reports